Key terms

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NEO news

Yesterday 7:26am ET NeoGenomics promotes Warren Stone to CCO, Melody Harris to COO by TipRanks Yesterday 7:12am ET NeoGenomics Announces Executive Team Restructuring and Appointments by TipRanks Feb 26 7:39am ET NeoGenomics price target raised to $20 from $18 at Piper Sandler by TipRanks Feb 24 10:06am ET NeoGenomics Launches Performance-Based Stock Incentive Plan by TipRanks Feb 22 12:15am ET Buy Rating Affirmed for NeoGenomics Amidst Strong Growth and Strategic Market Positioning by TipRanks Feb 21 5:13pm ET NeoGenomics price target raised to $19 from $17 at Goldman Sachs by TipRanks Feb 21 8:46am ET NeoGenomics (NEO) Receives a Buy from Craig-Hallum by TipRanks Feb 21 8:11am ET Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), NeoGenomics (NEO) and Ardelyx (ARDX) by TipRanks Feb 21 7:20am ET Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO), Axsome Therapeutics (AXSM) and Medtronic (MDT) by TipRanks Feb 21 7:19am ET NeoGenomics price target raised to $23 from $21 at BTIG by TipRanks Feb 21 7:17am ET NeoGenomics reports Q4 non-GAAP EPS 3c, consensus (2c) by TipRanks Feb 21 7:13am ET NeoGenomics price target raised to $21 from $19 at TD Cowen by TipRanks Feb 21 6:42am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Teladoc (TDOC) and NeoGenomics (NEO) by TipRanks Feb 21 5:40am ET Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and Bicycle Therapeutics (BCYC) by TipRanks Feb 21 5:28am ET NeoGenomics’ Solid Performance Tempered by Legal Risks: A Hold Rating Justified by TipRanks Feb 20 11:05pm ET NeoGenomics Earnings Beat with Upgraded Long-term Growth Forecast: Buy Rating Justified by TipRanks Feb 20 4:09pm ET NeoGenomics reports Q4 EPS (11c), consensus (2c) by TipRanks Feb 18 11:50pm ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks

No recent press releases are available for NEO

NEO Financials

1-year income & revenue

Key terms

NEO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NEO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days